Confronting the threat to compounded hormone therapy
JUMP: Resources • Tools • Background • Give now
IN 2021, THE ALLIANCE FOR PHARMACY COMPOUNDING LAUNCHED A CAMPAIGN TO PRESERVE PATIENT ACCESS TO COMPOUNDED HORMONES.
Together, we achieved much, but there remains so much to do. Our fight is not a bureaucratic struggle. For the millions of patients who depend on their compounded hormones to live normally, it is a potential health crisis.
For many providers and pharmacists this issue will determine the future of their practices.
The fight is not over. We need your support, your voice, your actions more than ever.
YEAR ONE: 2021
In the first year of our campaign, we successfully:
- Reached 25,000,000 patients, prescribers and physicians
- Engaged with more than 300,000 stakeholders
- Developed and launched compounding.com
- Filmed and launched multiple testimonial videos
- Produced our Compounding the Joy of Living video
- Produced a version of Compounding the Joy of Living for our pharmacists to use in their local markets
- Created in-store marketing materials for our pharmacists
- Funded a 3rd-party review of the NASEM report
- Published articles in STAT News and Everyday Health
- Produced multiple letters to Congress
- Featured in more than 100 podcast episodes
YEAR TWO: 2022
Standing up to FDA overreach
When we consider the future of compounding, 2022 may well prove a decisive point. And the fight over compounded hormones may prove to be the decisive issue. We must engage with patients, with practitioners, with relevant media and with Congress.
We must continue to make our voices heard and help people understand exactly what’s at stake. Most importantly, we need to inspire everyone affected by this issue to take action.
OUR 2022 GOAL: Raise $850,000+
In 2022, the money we raised was used on the following:
- Extensive advertising to all stakeholders of compounded hormones
- Focused effort to engage practitioners
- Developing and expanding compounding.com
- Unique media opportunities
- Added focus on patient testimonials
READ MORE ABOUT OUR 2022 GOALS
Year three: 2023
Taking back control
Other voices have been telling the story of compounding to the world, in the halls of FDA, in the chambers of Congress. Unfortunately, these voices have a vested interest in marginalizing compounding.
It’s time for us to take control of our own destiny.
APC’s Compounding the Joy of Living: The Campaign for Pharmacy Compounding is in the third year of our 3-year initiative to protect cBHT. Our goal is to raise $750,000.
We initially focused our efforts on hormones—and that fight continues—but this year we are expanding our mandate to secure the future of ALL compounding.
To learn more about APC’s Compounding the Joy campaign and how you can contribute your voice, please visit a4pc.org/impact
Resources and information
- Nearly 2,000 prescribers urge FDA: Preserve access to compounded hormones
- APC’s March 2022 briefing to prescribers (13-page PDF)
- APC’s December 2021 letter to FDA regarding cBHT access
- APC’s briefing paper on the issue
- NASEM’s overview of its recommendations (4-page PDF) and
the full NASEM cBHT report (350+page PDF). - Third-party analysis of the NASEM report, funded by the Pharmacy Compounding Foundation
- Summary of that analysis (2-page PDF)
- Full text of that analysis (27-page PDF)
- Video summary of the analysis
Tools you can use
Compounding.com: Read and share stories of cBHT’s impact on patients’ lives on APC’s cBHT Testimonial Portal — for cBHT patients, prescribers, and compounders. Share the link, too: Compounding.com/mystory.
Join the Cause: a four-page (PDF) brochure explaining the issue and urging people to contribute to the media campaign
Recruit your vendors: Here’s a sample letter (.docx format) you can customize and send your vendors, asking them to support the campaign to save cBHT.
Add prescribers’ voices: Here’s a sample letter for prescribers (.docx format) they can use to inform patients of the threat to cBHT.
Present the facts: a PowerPoint slide deck you can use in presentations for legislators, physicians, and even patients to explain the threat to cBHT
Inform your patients: a one-page patient-focused brief on the threat to cBHT, customizable by pharmacies. Available as a PDF or as a Word .docx file).
Share our video, The Joy of Living on social media and in your patient and prescriber communications.
More background information
- APC’s Statement on release of NASEM’s cBHT report
- FOIA-requested documents provide unambiguous evidence of bias in NASEM report.
- “So thoroughly compromised as to be useless”: APC press release on analysis of NASEM report
- Joint Congressional letter to FDA Commissioner Stephen Hahn
